obesity drug news today glp-1 2025 Market Size to Hit USD 66.57 Billion by 2035 Dozens of new obesity drugs
Description
Annual thyroid function testing may be prudent given theoretical thyroid concerns, though risk appears minimal in humans
Some patients find their maintenance dose is only one step below their therapeutic dose
This is the missing piece, and it is not a small one
The FDAs action also opened a door for Medicare coverage in patients with cardiovascular disease an early sign that access for these expensive medicines could expand beyond the well-insured
K.KankamM.LundM
Retatrutide Prescription and How to Get Retatrutide As of June 2026, retatrutide is still undergoing clinical trials and is not available for prescription
